Mankind Pharma’s operating margin widened to 27% from 24.9% a year earlier. Its board also approved plans to merge two wholly owned subsidiaries into the company.

E2E Networks said the proposed capacity addition would help it cater to the demand for GPUs and related services. The rollout will be guided by its infrastructure deployment plan and anticipated ...

Peter Kenyon, who formerly led Manchester United and Chelsea, said feedback in sports is constant and immediate.

The tech-heavy US index Nasdaq Composite is down 6 per cent since October 6, with Meta and NVIDIA falling 12-13 per cent and ...

The Paras Healthcare IPO allotment status is expected to be finalized on October 26, with listing on October 28. Check your ...

Apollo Micro Systems is also building capabilities in explosives and energetics through the IDL and the Premier Explosives ...

Jio Platforms raised about $3.1 billion through its record IPO, but intense competition among investment banks kept fees relatively low at around 0.65% of the issue size.

Motilal Oswal upgrades BSE to Buy with a Rs 4,000 target, sees 23% upside as SEBI's VWAP reversal and recovering derivatives volumes support growth prospects.

Choice said MRPL reported a 43.6 per cent year-on-year (YoY) rise in revenue to Rs 32,500 crore in the second quarter (Q2) of ...

CLSA analyst Saurabh Mehrotra maintained an 'Accumulate' rating on the stock and raised the target price to Rs 1,610 from Rs ...

Check share allotment online, subscription details, and GMP indicating a 22% listing premium ahead of the October 28 listing.

Tata Consumer Products, APL Apollo Tubes, Dalmia Bharat, ITC Hotels, Bank of Maharashtra, Mankind Pharma, Paytm, Nazara Tech, Kfin Tech, REC, Sona BLW, Indian Overseas Bank, Aegis Logistics, Aditya ...